DMAC · Categories · Form 4

DMAC - SEC Form 4 insider transactions

DiaMedica Therapeutics Inc. (DMAC) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for DMAC

• 115d
  Director Parsons James T. was granted 10,095 shares, increasing direct ownership by 11% to 97,949 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 115d
  Director Giuffre Randall Michael was granted 6,175 shares, increasing direct ownership by 2% to 398,587 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 115d
  Director Semba Charles Pauling was granted 3,355 shares, increasing direct ownership by 8% to 47,963 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 157d
  Director Parsons James T. exercised 12,000 shares at a strike of $2.20, increasing direct ownership by 16% to 87,854 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 179d
  SEC Form 4 filed by Chief Marketing Officer Krop Julie

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 332d
  SEC Form 4 filed by Chief Business Officer Wambeke David J.

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 332d
  SEC Form 4 filed by Director Semba Charles Pauling

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 332d
  SEC Form 4 filed by President & CEO Pauls Dietrich John

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 332d
  SEC Form 4 filed by Director Parsons James T.

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 332d
  SEC Form 4 filed by Director Lewis Tanya

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 332d
  SEC Form 4 filed by Director Kuntz Richard

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 332d
  SEC Form 4 filed by CFO & Secretary Kellen Scott

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 332d
  SEC Form 4 filed by Director Giuffre Randall Michael

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 388d
  Director Pilnik Richard D. exercised 24,000 units of Voting Common Shares at a strike of $2.11, increasing direct ownership by 8% to 312,995 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 431d
  SEC Form 4 filed by Director O'Connor Daniel J.

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 437d
  Director Giuffre Randall Michael exercised 17,000 units of Voting Common Shares at a strike of $2.56, increasing direct ownership by 5% to 392,412 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 483d
  Director Parsons James T. was granted 15,917 units of Voting Common Shares, increasing direct ownership by 27% to 75,854 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 483d
  Director Giuffre Randall Michael was granted 10,861 units of Voting Common Shares, increasing direct ownership by 3% to 375,412 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 483d
  Director Kuntz Richard was granted 9,925 units of Voting Common Shares, increasing direct ownership by 69% to 24,210 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 483d
  Director Pilnik Richard D. was granted 10,393 units of Voting Common Shares, increasing direct ownership by 4% to 288,995 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 483d
  Director Semba Charles Pauling was granted 5,290 units of Voting Common Shares, increasing direct ownership by 13% to 44,608 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 697d
  SEC Form 4 filed by Wambeke David J.

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 697d
  SEC Form 4 filed by Kellen Scott

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 697d
  SEC Form 4 filed by Cundari Dominic R

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 697d
  SEC Form 4 filed by Pauls Dietrich John

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 697d
  SEC Form 4 filed by Semba Charles Pauling

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 697d
  SEC Form 4 filed by Pilnik Richard D.

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 697d
  SEC Form 4 filed by Parsons James T.

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 697d
  SEC Form 4 filed by Lewis Tanya

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 697d
  SEC Form 4 filed by Kuntz Richard

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 697d
  SEC Form 4 filed by Giuffre Randall Michael

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 829d
  SEC Form 4 filed by Lorianne Masuoka K.

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 850d
  Semba Charles Pauling was granted 9,375 units of Voting Common Shares, increasing direct ownership by 31% to 39,318 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 850d
  Kuntz Richard was granted 14,285 units of Voting Common Shares (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 850d
  Pilnik Richard D. was granted 30,357 units of Voting Common Shares, increasing direct ownership by 12% to 278,602 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 850d
  Parsons James T. was granted 21,428 units of Voting Common Shares, increasing direct ownership by 56% to 59,937 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 850d
  Giuffre Randall Michael was granted 19,196 units of Voting Common Shares, increasing direct ownership by 6% to 364,551 units (SEC Form 4)

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1039d
  SEC Form 4 filed by Von Koch Thomas

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1040d
  SEC Form 4 filed by Pauls Dietrich John

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1040d
  SEC Form 4 filed by Semba Charles Pauling

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1040d
  SEC Form 4 filed by Kellen Scott

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1040d
  SEC Form 4 filed by Wambeke David J.

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1040d
  SEC Form 4 filed by Pilnik Richard D.

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1064d
  SEC Form 4 filed by Daves Julie Vanorsdel

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1064d
  SEC Form 4 filed by Cundari Dominic R

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1064d
  SEC Form 4 filed by Gruis Kirsten L

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1064d
  SEC Form 4 filed by Kellen Scott

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1064d
  SEC Form 4 filed by Pauls Dietrich John

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1064d
  SEC Form 4 filed by Semba Charles Pauling

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1064d
  SEC Form 4 filed by Pilnik Richard D.

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1064d
  SEC Form 4 filed by Parsons James T.

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1064d
  SEC Form 4 filed by Lewis Tanya

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1064d
  SEC Form 4 filed by Giuffre Randall Michael

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1067d
  SEC Form 4 filed by Kuntz Richard

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1116d
  SEC Form 4 filed by Wambeke David J.

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1214d
  SEC Form 4: Giuffre Randall Michael was granted 35,130 units of Voting Common Shares, increasing direct ownership by 13% to 295,355 units

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1214d
  SEC Form 4: Burroughs Amy L. was granted 17,156 units of Voting Common Shares, increasing direct ownership by 31% to 73,288 units

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1214d
  SEC Form 4: Semba Charles Pauling was granted 17,156 units of Voting Common Shares

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1214d
  SEC Form 4: Pilnik Richard D. was granted 55,555 units of Voting Common Shares, increasing direct ownership by 36% to 209,882 units

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)
• 1236d
  SEC Form 4: Giuffre Randall Michael bought $81,023 worth of Voting Common Shares (57,079 units at $1.42), increasing direct ownership by 28% to 260,225 units

  4 - DiaMedica Therapeutics Inc. (0001401040) (Issuer)

Other DMAC categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends